BACKGROUND: Our practical experience indicates that sexual side-effects in subjects taking finasteride 1 mg (Propecia) for androgenetic alopecia are much less common than reported in the literature. OBJECTIVE: To evaluate the sexual function in subjects taking finasteride (1 mg) compared with age-matched controls using the International Index of Erectile Function (IIEF). METHODS: The IIEF, a brief, reliable questionnaire, was self-administered to 236 patients taking Propecia and 236 age-matched males attending the Department of Dermatology of the University of Bologna. RESULTS: Statistical analysis showed no differences between scores obtained with the IIEF in subjects taking finasteride and controls. CONCLUSIONS: The sexual and erectile function of subjects taking finasteride does not significantly differ from that of age-matched controls. This is consistent with the experience of many dermatologists who do not see sexual or erectile dysfunction in patients taking Propecia. content2 |
|
More Info: Home | About Regrowth.com | How
to Advertise | Privacy Policy | Advertising
Policy | Contact Us
Site Map | Copyright © 2007
The Regrowth Network. All rights reserved. Legal Disclaimer
Other Cool Sites: Hair Loss Treatments - Body for Life Tracker - MedSpert
Propecia ® is
a registered trademark of Merck.
Avodart ® is a
registered trademark of GlaxoSmithKline.
Rogaine ® is a
registered trademark of Pfizer. Nizoral ® is
a registered trademark of McNeil Consumer & Specialty Pharmaceuticals.